{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Intraoperative End-Tidal Carbon Dioxide and Recurrence-Free Survival in Pancreatic Cancer Surgery: A Retrospective Cohort Study"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "This single-center, retrospective cohort study included 652 patients who underwent elective pancreatic cancer resection at Heidelberg University Hospital between 2009 and 2016."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients were categorized into high-EtCO2 and low-EtCO2 groups based on mean intraoperative EtCO2 values."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aims to explore the relationship between EtCO2 levels and recurrence-free survival in pancreatic cancer surgery."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was recurrence-free survival, with secondary outcomes including cardiovascular events, surgical site infections, sepsis, reoperations, and overall survival."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "This single-center, retrospective cohort study included 652 patients who underwent elective pancreatic cancer resection at Heidelberg University Hospital between 2009 and 2016."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "There was no significant difference in recurrence-free survival between the high and low EtCO2 groups [HR = 1.043 (95% CI: 0.875\u20131.243), p = 0.909]."
      },
      "Harms": {
        "score": 1,
        "evidence": "secondary outcomes including cardiovascular events, surgical site infections, sepsis, reoperations, and overall survival."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not applicable."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 12,
    "max_score": 25
  },
  "model": "gpt-4o"
}